A collaborative effort between Washington University in St. Louis, Agilent Technologies and the biopharmaceutical company Merck aims to expand research in the field of metabolomics, the comprehensive study of small molecules within a biological system. Using top-of-the-line research instrumentation from Agilent, scientists in the Department of Chemistry in Arts & Sciences will develop new metabolomics […]
Washington University collaborates with Agilent, Merck to expand metabolomics research
